2025³â 08¿ù 05ÀÏ È­¿äÀÏ
 
 
  ÇöÀçÀ§Ä¡ > Àαⴺ½º

·£¼¶¿þ¾îºÎÅÍ µÅÁöµµ»ì±îÁö... ³ë·ÃÇØÁø »ç±âÇà°¢

 

Á¤Ä¡

 

°æÁ¦

 

»çȸ

 

»ýȰ

 

¹®È­

 

±¹Á¦

 

°úÇбâ¼ú

 

¿¬¿¹

 

½ºÆ÷Ã÷

 

ÀÚµ¿Â÷

 

ºÎµ¿»ê

 

°æ¿µ

 

¿µ¾÷

 

¹Ìµð¾î

 

½Å»óǰ

 

±³À°

 

ÇÐȸ

 

½Å°£

 

°øÁö»çÇ×

 

Ä®·³

 

Ä·ÆäÀÎ
Çѻ츲 ¡®¿ì¸®´Â ÇѽҸ²¡¯ ½Ò ¼Òºñ Ä·ÆäÀÎ ½Ã...
1000¸¸¿øÂ¥¸® Àΰø¿Í¿ì, °Ç°­º¸Çè Áö¿ø ¡®Æò...
 
¸ðµÎ 92443°³ÀÇ ´º½º°¡ °Ë»öµÇ¾ú½À´Ï´Ù.



¡®±ñdzġŲ »À ¹ß¶ó¹ö¸± ¹ß°ñ Àü¹®°¡¡¯ ¸ðÁý¡¦ÀÏ±Þ 100¸¸¿ø

ÀâÄÚ¸®¾Æx¾Ë¹Ù¸óxǪ¶ó´ß º¹³¯ ÀÌ»ö¾Ë¹Ù
ÀâÄÚ¸®¾Æ¿Í ¾Ë¹Ù¸ó(´ëÇ¥ÀÌ»ç À±ÇöÁØ)ÀÌ º¹³¯À» ¸Â¾Æ ġŲ Àü¹® ºê·£µå Ǫ¶ó´ß ġŲ°ú ÇÔ²² ÀÌ»ö ¾Ë¹Ù¸¦ ¸ðÁýÇÏ´Â À̺¥Æ®¸¦ ÁøÇàÇÑ´Ù°í 21ÀÏ ¹àÇû´Ù. ÀâÄÚ¸®¾Æ¿Í ¾Ë¹Ù¸óÀº ³»´Þ 3ÀϱîÁö Ǫ¶ó´ß ġŲ°ú Çù¾÷ÇØ º¹³¯ ±â³ä ÀÌ»ö °ø°í¸¦ ³»°í ‘±ñdzġŲ »À ¹Ù¸¦ ¾Ë¹Ù¸ó’°ú ‘±ñdzġŲ »À ¹ß¶ó¹ö¸± ¹ß°ñ Àü¹®°¡’¸¦ ¸ðÁýÇÑ´Ù. À̹ø À̺¥Æ®´Â ¾Ë¹Ù¸óÀÌ ÁøÇà ÁßÀÎ ´ë±Ô¸ð ÇÁ·Î¸ð¼Ç ‘2025 ¿©¸§ ¾Ë¹Ù Æä½ºÅ¸(¿©¾ËÆä)’ÀÇ ÀÏȯÀÌ´Ù. ÀâÄÚ¸®¾Æ¿Í ¾Ë¹Ù¸óÀº ¿©¸§Ã¶ ¹«´õÀ§¿Í ²ß²ßÇÑ ³¯¾¾·Î ÁöÃÄ ÀÖ´Â ±¸Á÷ÀÚµéÀ» À§ ...

¡®¹®ÇÐÀ¸·Î ¸¸µå´Â ¸¶À½ÀÇ Æò¾È, ±Ý°­À§Å©¡¯ °³ÃÖ

»ó¼³ üÇèºÎÅÍ »ê»ç Äܼ­Æ®, ¸í»çÃÊû¹ýȸ±îÁö¡¦ ½ÅÁß³âÃþ ¸ÂÃã ÇÁ·Î±×·¥
º¸ÇöÇà¿øÀ» ½ÇõÇÏ´Â Àü¹ýµµ·® ´ëÇѺұ³Á¶°èÁ¾ ±Ý°­Á¤»ç(ÁÖÁö °¡¼·½º´Ô)°¡ 8¿ù 1ÀϺÎÅÍ 10¿ù 31ÀϱîÁö 3°³¿ù°£ ¹®ÇÐÀ» ÅëÇÑ ¸¶À½ Ä¡À¯ ÇÁ·Î±×·¥ ‘Á¦3ȸ ¹®ÇÐÀ¸·Î ¸¸µå´Â ¸¶À½ÀÇ Æò¾È, ±Ý°­À§Å©(ÁÖÃÖ ¹× ÁÖ°ü: ´ëÇѺұ³Á¶°èÁ¾ ±Ý°­Á¤»ç, ÈÄ¿ø: °æ±âµµ)’¸¦ ÁøÇàÇÑ´Ù°í 30ÀÏ ¹àÇû´Ù. °æ±âµµ ±¤¸í½Ã¿¡ À§Ä¡ÇÑ ±Ý°­Á¤»ç´Â ȸÁÖ½º´ÔÀ̽Šº®¾Ï(ÁöÈ«)½º´Ô°ú Àç°¡ºÒÀÚµéÀÇ ¿ø·ÂÀ¸·Î ºÒ±â 2535³â(1991³â) 1¿ù °³¿øÇÑ ½ÅÇà °øµ¿Ã¼´Ù. È£¹ý¹ýȸ ¹× ÀÏ¿ä¹ýȸ µî ´Ù¾çÇÑ Á¤±â¹ýȸ¸¦ ºñ·ÔÇØ ‘³» ¸¶À½ÀÇ Çູ¿©Çà(1¹Ú2ÀÏ Ã¼ÇèÇü)&rs ...

Novotech Report: How In-Vivo CAR-T May Reshape Cell Therapy Econo...
SYDNEY -- With in-vivo CAR-T therapies gaining global momentum, a new whitepaper from Novotech, a leading global full-service clinical Contract Research Organization (CRO) and scientific advisory company, offers insight into this next frontier of immunotherapy. In-Vivo CAR Therapies - Global Research and Development Landscape (2025) report explores the accelerating innovation in in-vivo CAR-T (Chimeric Antigen Receptor) technologies and their potential to reshape treatment across oncology, autoi ...
¸¸¼ºÁúȯ ¾î¸£½ÅÀÇ ½Ä»ýȰ Áö¿ø ¡®»çÀÌ´Ù¡¯ Ä·ÆäÀÎ (2021-11-09)
°æÇÇÅõ°úÇü º¸Åø¸®´® µ¶¼Ò ÀçÁ¶ÇÕ ´Ü¹éÁú »ý»ê ½ÂÀÎ (2020-08-19)
¾ÖÀú ´ëºñ 180ºÐÀÇ 1 °¡°Ý À©µµ¿ì Ŭ¶ó¿ìµå (2018-03-26)
ÇϹݱâ ÁÖ¿ä ±â¾÷ ¹× °ø±â¾÷ ä¿ë (2018-09-19)
¼­¿ï½Ã, Àü±¹ ÃÖÃÊ ÇÃ¶ó½ºÆ½ÇÁ¸®µµ½Ã µµÀü (2018-09-19)
¸ð¹ÙÀÏ °ÔÀÓ °ü·Ã »óÇ¥Ãâ¿ø 2.2¹è Áõ°¡ (2016-08-21)
´ëÇÑÀü¼±, Ãʰí¾Ð ÇÁ·ÎÁ§Æ® ¼º°ú (2022-08-31)
3D ¸ð¼Ç ¼Ö·ç¼Ç ¡®¹«¹ö½º¡¯ ÇØ¿Ü ½ÃÀå °Ü³ÉÇÑ´Ù (2023-07-09)
°Çº¸°ø´Ü, ¡®2018³âµµ °¡Á·»ó´ã Áö¿ø»ç¾÷¡¯ È®´ë (2018-02-20)
±¹³» ±â»ó»ê¾÷ ½ÃÀå 4000¾ï¿ø µ¹ÆÄ (2018-10-31)
º¼º¸°Ç¼³±â°è, ¿À´ë»ê ±¹¸³°ø¿ø »ýÅÂ°è º¹¿ø (2018-04-20)
LG, Àü¿ë¼­Ã¼ ¡®LG ½º¸¶Æ®Ã¼¡¯ °³¹ß (2014-12-31)
¸¶ÄÉÆÃ¡¤È«º¸ °æ·ÂÁ÷ ä¿ë °ø°í (2021-01-26)
¡®Ã¶Ç÷»ï±¹¡¯ Àεµ³×½Ã¾Æ ÆÛºí¸®½Ì °è¾à (2021-01-26)
³îºÎºÎ´ëÂî°³, Â¥±ÛÀÌ ½Å¸Þ´º ¡®¿ì°ö»õ¡¯ Ãâ½Ã (2019-04-26)
Alvotech, a Global Pureplay Biosimilars Company, to Debut on... (2022-06-16)
µµ½Ã¹Ù, ´ë¸¸ NAND Ç÷¡½Ã ¸Þ¸ð¸® ƯÇã ¼Ò¼Û (2014-06-03)
¸ðµç À½·á¸¦ ½½·¯½Ã·Î ¹Ù²Ù´Â °ú³Ã°¢±â ¡®½º³ëÆÄ¡¯ (2014-06-03)
LG CNS-°æÈñ´ë, ¡®ÀÌÀ½5G ±¸Ãà ¹× ¿¬±¸¡¤°³¹ß¡¯ MOU (2023-02-24)
µ¿¿ø±×·ì, 2020³â »ó¹Ý±â ä¿ë¿¬°èÇü ÀÎÅÏ ¸ðÁý (2020-05-01)
¹ÌÈ¥ ³²³à °í°´ À§ÇÑ ´Ù¾çÇÑ ÇýÅá¤À̺¥Æ® Á¦°ø (2022-02-01)
¹Î°ü ºòµ¥ÀÌÅÍ ¸ð¾Æ ¼Ò»ó°øÀÎ µ½´Â´Ù (2021-07-22)
Àü±âÂ÷ ÇöÀç 1À§ Ú¸, 5³âÈÄ 1À§ ùÛ, ÃÖ´ë À§Çù ñé (2023-06-22)
´ëÇлý 67%, Äڷγª19 ¶§¹®¿¡ ¹æÇаèȹ º¯È­ (2020-06-12)
¸Á¿ì¸®°í°³¿¡ ±³·® ½Å¼³ (2014-03-10)
       [ÀÌÀü][1]....[2595][2596][2597][2598][2599][2600][2601][2602][2603]...[3698][´ÙÀ½]

°øÁö»çÇ×
´º½ºÁö ÇÑÀÚ Ç¥±â¿¡ ´ë¸¸½Ä À½Â÷ Ç¥±â '纽ÞÙó¢ ´Ï¿ì½ÃÁö' º´±â
º£³×ÇÁ·Ò º£³×ÀÎÅõ Áß¹® Ç¥±â 宝Ò¬ÜØÙÌ 宝Ò¬ì×öõ(ÜÄÒ¬ÜØÙÌ ÜÄ...
¹Ìµð¾î¾Æ¿ì¾î Mediaour ØÚ体ä²们 ØÚô÷ä²Ùú MO ¿¥¿À ØÚä² ØÚä²
¾Ë¸®¿ìºê Alliuv ä¹备: ä¹联êó备, ¾Ë¶ã Althle ä¹÷åìÌ
¾Ë¸®¾Ë Allial Áß¹® Ç¥±â ä¹××尔 ä¹××ì³
´ºÆÛ½ºÆ® New1st Áß¹® Ç¥±â 纽ììãæ(¹øÃ¼ Òïììãæ), N1 纽1
¿£ÄÚ½º¸ð½º : À̾¾ 'EnCosmos : EC' Áß¹® Ç¥±â ì¤ñµ
¾ÆÀ̵ð¾î·Ð Idearon Áß¹® Ç¥±â ì¤îè论 ì¤îèÖå
¹ÙÀÌ¿ÀÀÌ´Ï Bioini Áß¹® Ç¥±â ù±药研 ù±å·æÚ
¿À½ºÇÁ·Ò Ausfrom 奥ÞÙÜØÙÌ, À£ÇÁ·Ò Welfrom 卫ÜØÙÌ
¿¡³ÊÇÁ·Ò Enerfrom 额ÒöÜØÙÌ ¿¡³ÊÀ¯ºñ Eneruv 额Òöêó备
¾ËÇÁ·Ò Alfrom Áß¹® Ç¥±â ä¹尔ÜØÙÌ ä¹ì³ÜØÙÌ
 

ȸ»ç¼Ò°³ | ÀÎÀçä¿ë | ÀÌ¿ë¾à°ü | °³ÀÎÁ¤º¸Ãë±Þ¹æÄ§ | û¼Ò³âº¸È£Á¤Ã¥ | Ã¥ÀÓÇѰè¿Í ¹ýÀû°íÁö | À̸ÞÀÏÁÖ¼Ò¹«´Ü¼öÁý°ÅºÎ | °í°´¼¾ÅÍ

±â»çÁ¦º¸ À̸ÞÀÏ news@newsji.com, ÀüÈ­ 050 2222 0002, ÆÑ½º 050 2222 0111, ÁÖ¼Ò : ¼­¿ï ±¸·Î±¸ °¡¸¶»ê·Î 27±æ 60 1-37È£

ÀÎÅͳݴº½º¼­ºñ½º»ç¾÷µî·Ï : ¼­¿ï ÀÚ00447, µî·ÏÀÏÀÚ : 2013.12.23., ´º½º¹è¿­ ¹× û¼Ò³âº¸È£ÀÇ Ã¥ÀÓ : ´ëÇ¥ CEO

Copyright ¨Ï All rights reserved..